5-151505761-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001447.3(FAT2):c.12854G>T(p.Gly4285Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAT2 | NM_001447.3 | c.12854G>T | p.Gly4285Val | missense_variant | 24/24 | ENST00000261800.6 | NP_001438.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAT2 | ENST00000261800.6 | c.12854G>T | p.Gly4285Val | missense_variant | 24/24 | 1 | NM_001447.3 | ENSP00000261800.5 | ||
FAT2 | ENST00000520200.5 | c.3170G>T | p.Gly1057Val | missense_variant | 11/11 | 1 | ENSP00000429678.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461514Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727086
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.12854G>T (p.G4285V) alteration is located in exon 23 (coding exon 23) of the FAT2 gene. This alteration results from a G to T substitution at nucleotide position 12854, causing the glycine (G) at amino acid position 4285 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at